Non-Small Cell Lung Cancer Treatment Includes Different Options Including Chemotherapy and Surgery Depending On Requirement of Patients
Non-Small Cell Lung Cancer Treatment |
Among the various options for non-small cell lung cancer treatment is
chemotherapy. The best non-surgical treatment for this type of cancer is
radiation therapy, which is also known as stereotactic body radiation therapy
(SBRT). The patient's overall health is an important factor in deciding on
which Non-Small Cell Lung Cancer Treatment to receive. Patients with
stage 0 NSCLC may be eligible for surgery alone. Chemoradiation is often used
in combination with chemotherapy. This type of treatment may result in complete
cure, depending on the extent of cancer spread and the lymph nodes involved.
While it may not cure the cancer, this treatment will shrink the tumor,
relieve symptoms, and slow the spread of the disease. Most people with
non-small cell lung cancer undergo four to six cycles of treatment over three
to six months. After the first treatment, the patient may require maintenance
chemotherapy, a different type of chemotherapy, or both. The process of
chemotherapy for lung cancer treatment involves the administration of different
medicines, which may include a combination of different drugs. These medicines
are usually given intravenously through a tube connected to a blood vessel in
the chest. Others may be given the medicines by capsules.
Surgery is typically the first step in non-small cell lung cancer
treatment. Stage I, II, and IIIA Non-Small
Cell Lung Cancer Treatment patients often have the tumor
removed surgically. The surgeon may remove a lobe or part of the lung. If the
cancer has spread to nearby lymph nodes, those nodes may also be removed.
Several other surgical procedures are available, including a thoracoscopy,
where a surgeon inserts a camera through a small incision in the chest.
Surgery isn't commonly used in Non-Small Cell Lung Cancer Treatment.
However, it may be an option if the cancer is in an early stage and has spread
to other organs. Surgery can also be combined with chemotherapy or radiotherapy
to reduce the risk of cancer recurring. In some cases, a surgeon may decide to
remove the entire lung. The cancer may have spread to the lining of the lung or
has spread throughout the lung. In May 2022, Chugai Tecentriq received
regulatory approval in Japan for adjuvant treatment of non-small cell lung
cancer as the first immunotherapy.
Comments
Post a Comment